Search

Your search keyword '"Tetracyclines therapeutic use"' showing total 1,247 results

Search Constraints

Start Over You searched for: Descriptor "Tetracyclines therapeutic use" Remove constraint Descriptor: "Tetracyclines therapeutic use"
1,247 results on '"Tetracyclines therapeutic use"'

Search Results

1. Immunomodulatory activity of omadacycline in vitro and in a murine model of acute lung injury.

2. Evaluating omadacycline dosing regimens against drug-resistant pathogens including Staphylococcus aureus , Streptococcus pneumoniae and Haemophilus influenzae in adults: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation.

3. New-generation tetracyclines for severe macrolide-resistant Mycoplasma pneumoniae pneumonia in children: a retrospective analysis.

4. [Comparison of efficacy and safety between elacycline and polymyxin for complicated intra-abdominal infections caused by multidrug-resistant bacteria].

5. Zidovudine in synergistic combination with nitrofurantoin or omadacycline: in vitro and in murine urinary tract or lung infection evaluation against multidrug-resistant Klebsiella pneumoniae .

6. Possible omadacycline induce acute pancreatitis: a case report and literature review.

7. Omadacycline is active in vitro and in vivo against ciprofloxacin-resistant Bacillus anthracis .

8. Assessment of pharmacokinetics-pharmacodynamics to support omadacycline dosing regimens for the treatment of patients with acute bacterial skin and skin structure infections.

9. Innovations in Acne.

10. Omadacycline for the treatment of severe Legionella pneumophila pneumonia complicated with multiple organ dysfunction: a case report.

11. Evaluation of omadacycline regimens for community-acquired bacterial pneumonia patients infected with Staphylococcus Aureus by pharmacokinetic/pharmacodynamic analysis.

12. Deleterious effects of a combination therapy using fluoroquinolones and tetracyclines for the treatment of Japanese spotted fever: a retrospective cohort study based on a Japanese hospital database.

13. Use of Eravacycline for Acinetobacter baumannii Infections: A Case Series.

14. Efficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model of M. abscessus lung disease.

15. Third-Generation Tetracyclines: Current Knowledge and Therapeutic Potential.

16. Efficacy of omadacycline in the treatment of Legionella pneumonia : a case report.

17. A Review of Omadacycline for Potential Utility in the Military Health System for the Treatment of Wound Infections.

18. Efficacies of three drug regimens containing omadacycline to treat Mycobacteroides abscessus disease.

19. Guidelines of care for the management of acne vulgaris.

20. 45 years of tetracycline post exposure prophylaxis for STIs and the risk of tetracycline resistance: a systematic review and meta-analysis.

21. Combination eravacycline therapy for ventilator-associated pneumonia due to carbapenem-resistant Acinetobacter baumannii in patients with COVID-19: A case series.

22. State-transition modeling of blood transcriptome predicts disease evolution and treatment response in chronic myeloid leukemia.

23. Eravacycline, an antibacterial drug, repurposed for pancreatic cancer therapy: insights from a molecular-based deep learning model.

24. Application of omadacycline in the treatment of severe Japanese spotted fever.

26. Systematic Review: Clinical Features, Antimicrobial Treatment, and Outcomes of Human Tularemia, 1993-2023.

27. Tularemia Clinical Manifestations, Antimicrobial Treatment, and Outcomes: An Analysis of US Surveillance Data, 2006-2021.

28. Fecal Pharmacokinetics and Gut Microbiome Effects of Oral Omadacycline Versus Vancomycin in Healthy Volunteers.

29. Pharmacokinetic and pharmacodynamic evaluation of the atypical tetracyclines chelocardin and amidochelocardin in murine infection models.

30. Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022.

31. The combination of tetracyclines effectively ameliorates liver fibrosis via inhibition of EphB1/2.

32. Omadacycline therapy for Mycobacterium abscessus species infections.

33. Pharmacological Management of Cholera: A Century of Expert Opinions in Cecil Textbook of Medicine.

34. Practice Patterns and Clinician Opinions for Treatment of Ocular Rosacea.

35. Rosacea in children: a review.

36. Case Report: Omadacycline in the treatment of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in an adolescent patient.

37. The pharmacokinetic evaluation of omadacycline (Oral Only Dosing Regimen) for the treatment of Community-Acquired Bacterial Pneumonia (CABP).

38. Clinical Effectiveness of Tetracycline-Class Agents Based Regimens in Patients With Carbapenem-Resistant Acinetobacter baumannii Bacteremia: A Single-Center Retrospective Cohort Study.

39. [Multidisciplinary expert consensus on the rational use of tetracyclines commonly used in clinical practice].

40. Omadacycline pharmacokinetics/pharmacodynamics in the hollow fiber model and clinical validation of efficacy to treat pulmonary Mycobacterium abscessus disease.

41. In Vitro Synergistic Effects of Omadacycline with Other Antimicrobial Agents against Mycobacterium abscessus.

42. Collateral sensitivity between tetracyclines and aminoglycosides constrains resistance evolution in carbapenem-resistant Klebsiella pneumoniae.

43. Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease.

44. Evaluation of the Impact of Comorbidities on Omadacycline Pharmacokinetics.

45. Omadacycline in treating community-based infections: a review and expert perspective.

46. In Vitro Antimicrobial Activities of Tigecycline, Eravacycline, Omadacycline, and Sarecycline against Rapidly Growing Mycobacteria.

47. Clinical impact of tetracyclines and/or proton pump inhibitors on the efficacy of epidermal growth factor receptor inhibitors in non-small cell lung cancer: a retrospective cohort study.

48. Changes in Streptococcus pneumoniae Susceptibility in Wisconsin: Implications for Clinical Treatment Decisions for Respiratory Infections.

49. Re-establishing the utility of tetracycline-class antibiotics for current challenges with antibiotic resistance.

50. Omadacycline for management of Mycobacterium abscessus infections: a review of its effectiveness, place in therapy, and considerations for use.

Catalog

Books, media, physical & digital resources